Script Training for Aphasia
(MIDAS Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate how changing conditions of speech-language treatment (namely, amount of repetition and distribution of practice schedule) affects the language outcome of participants with aphasia following a stroke. Using a computer based speech and language therapy program, participants will practice conversational scripts that are either short or long. Participants will practice for either 2 weeks (5 days a week) or for 5 weeks (2 days a week).
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that participants should not be receiving speech-language therapy at the time of the study.
What data supports the effectiveness of the treatment Script Training for Aphasia?
Research shows that script training, including computer-based methods, can significantly improve speech and language skills in people with aphasia, helping them use practiced phrases in real conversations. This approach is effective for both stable and progressive forms of aphasia, and improvements can be maintained over time.12345
Is script training for aphasia safe for humans?
How is script training for aphasia different from other treatments?
Script training for aphasia is unique because it involves practicing specific phrases and sentences repeatedly, which can be used in real-life conversations. This treatment can be delivered via computer with a virtual clinician, allowing for flexible and intensive practice, and it has been shown to improve communication in both stable and progressive forms of aphasia.12358
Research Team
Leora Cherney, PhD, CCC-SLP
Principal Investigator
Shirley Ryan Abilitylab, Northwestern University
Eligibility Criteria
This trial is for men and women who have aphasia after a left-hemisphere stroke. They should be at least 6 months post-stroke, with an Aphasia Quotient score of 40-80 on the Western Aphasia Battery-Revised. Participants must have completed eighth grade, be literate in English, not currently receiving speech therapy, and have adequate vision and hearing. Those with active substance abuse, other neurological conditions affecting cognition/speech or significant psychiatric history are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants practice conversational scripts using a computer-based speech and language therapy program. The practice varies between 2 weeks (5 days a week) and 5 weeks (2 days a week) depending on the assigned group.
Follow-up
Participants are monitored for maintenance of trained script and generalization of conversation skills.
Treatment Details
Interventions
- Modulating Intensity and Dosage of Aphasia Scripts
Modulating Intensity and Dosage of Aphasia Scripts is already approved in United States, European Union, Canada for the following indications:
- Aphasia following stroke
- Aphasia following stroke
- Language disorders
- Aphasia following stroke
- Language disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
Northwestern University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of Colorado, Boulder
Collaborator